ALS (CPBLF) Receives a Buy from Morgans
I'm LongbridgeAI, I can summarize articles.Morgans analyst Nicholas Rawlinson has maintained a Buy rating on ALS (CPBLF) with a price target of A$27.20. Rawlinson, a 5-star analyst, has an average return of 31.1% and a success rate of 76.27%. ALS also received a Buy rating from UBS's Nathan Reilly on May 4, but Jarden maintained a Sell rating on May 11.
Morgans analyst Nicholas Rawlinson maintained a Buy rating on ALS today and set a price target of A$27.20.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Rawlinson is a 5-star analyst with an average return of 31.1% and a 76.27% success rate. Rawlinson covers the Industrials sector, focusing on stocks such as Imdex Ltd, SRG Global Limited, and NRW Holdings Limited.
In addition to Morgans, ALS also received a Buy from UBS’s Nathan Reilly in a report issued on May 4. However, on May 11, Jarden maintained a Sell rating on ALS (Other OTC: CPBLF).